Showing results (871-880 of 986) with videos related to
Sort By:
Pageof 99
Trials|May 19, 2010
The Chest Pain Choice trial: a pilot randomized trial of a decision aid for patients with chest pain in the emergency departmentMeghan A Pierce, Erik P Hess, Jeffrey A Kline, et al.Investigative Ophthalmology & Visual Science|September 24, 2010
Identification of disease-causing mutations in autosomal dominant retinitis pigmentosa (adRP) using next-generation DNA sequencingSara J Bowne, Lori S Sullivan, Daniel C Koboldt, et al.Blood|March 29, 2003
The minor histocompatibility antigen HA-3 arises from differential proteasome-mediated cleavage of the lymphoid blast crisis (Lbc) oncoproteinEric Spierings, Anthony G Brickner, Jennifer A Caldwell, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|December 14, 2004
Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung diseaseDonald C McCurnin, Richard A Pierce, Ling Yi Chang, et al.Ejhaem|July 18, 2022
A prognostic model integrating PET-derived metrics and image texture analyses with clinical risk factors from GOYALale Kostakoglu, Federico Dalmasso, Paola Berchialla, et al.Investigative Ophthalmology & Visual Science|October 23, 2018
Clinical Features of a Retinopathy Associated With a Dominant Allele of the RGR GeneRola Ba-Abbad, Monique Leys, Xinjing Wang, et al.International Journal of Hematology|March 5, 2019
Incidence of second malignancies in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitorsKoji Sasaki, Hagop M Kantarjian, Susan O'Brien, et al.Plos One|February 8, 2018
The peroxisome proliferator-activated receptor agonist pioglitazone and 5-lipoxygenase inhibitor zileuton have no effect on lung inflammation in healthy volunteers by positron emission tomography in a single-blind placebo-controlled cohort studyDelphine L Chen, Howard J Huang, Derek E Byers, et al.European Journal of Cancer (Oxford, England : 1990)|November 15, 2008
Harmonisation of multi-centre real-time reverse-transcribed PCR results of a candidate prognostic marker in breast cancer: an EU-FP6 supported study of members of the EORTC - PathoBiology GroupP N Span, A M Sieuwerts, J J T M Heuvel, et al.Critical Care Medicine|May 5, 2018
Insidious Harm of Medication Diluents as a Contributor to Cumulative Volume and Hyperchloremia: A Prospective, Open-Label, Sequential Period Pilot StudyCarolyn A Magee, Melissa L Thompson Bastin, Melanie E Laine, et al.Pageof 99